Premature Birth Drug Makena Withdrawn By Maker Covis After FDA Committee Vote
ZUG, Switzerland — Covis Pharma Group on March 7 said in a press release that it is seeking to voluntarily withdraw its premature birth prevention drug Makena from the U.S. market...To view the full article, register now.
Already a subscriber? Click here to view full article